The benefits of publishing your research in Adis journals
Adis is an independent and reputable publisher with a large global readership of healthcare practitioners, researchers and decision makers with an interest in drugs and related areas, including other therapeutic or diagnostic interventions. We understand the needs of authors and publication managers involved in drug research and offer rapid and responsive personal service to ensure that you find the right home for every article.
Reputable publisher
Adis has more than 40 years’ experience in publishing medical journals with a reputation for excellence
Article discoverability
- Most Adis journals are PubMed- or Medline-indexed, and all offer Open Access publishing options
- Adis content benefits from the superior search engine optimization and semantic linking afforded by Springer’s global content platforms
Large and global readership
- Adis journals are available via Springer subscriptions to thousands of institutions worldwide
- Open Access content is available to anyone in the world, also on the Springer platform
- Readership comprises healthcare practitioners, researchers and decision makers with an interest in drugs or other therapeutic / diagnostic interventions and healthcare outcomes
Flexible publishing options
- Adis Rapid+ journals offer publication in 4-6 weeks. Every article is published with a bulleted summary slide to encourage access to a wider readership. Additional enhanced features such as slide decks, animations, videos and interactive learning resources can be published alongside the article, and all are peer reviewed to the same high standards.
- All Adis subscription titles offer Open Access publication at the author’s choice, and we offer a fully Open Access portfolio of 13 titles covering many therapeutic areas
- Submissions of positive, negative and confirmatory studies welcomed
Personalized author support
- Pre-submission inquiries are welcomed and expert editorial assistance will be provided throughout the publication process
- Cascading peer review encouraged – our Editors are happy to discuss a manuscript and identify the perfect vehicle for any article
- A wealth of resources are available on springer.com including manuscript guidelines, journal selection tools and AuthorZone
- All Adis authors receive a 33% discount on all Springer books for life
Independent and unbiased
- All submissions are subject to a thorough peer-review process to ensure that all Adis-published content is scientifically sound, unbiased and relevant to our readers. Read more about this process here
- Adis endorses ICMJE / WAME/ COPE guidelines and codes of conduct for journal Editors, and encourages authors of sponsored research to comply with Good Publication Practice (GPP). All submissions are subject to peer review.